Literature DB >> 19122659

Development of a novel mouse glioma model using lentiviral vectors.

Tomotoshi Marumoto1, Ayumu Tashiro, Dinorah Friedmann-Morvinski, Miriam Scadeng, Yasushi Soda, Fred H Gage, Inder M Verma.   

Abstract

We report the development of a new method to induce glioblastoma multiforme in adult immunocompetent mice by injecting Cre-loxP-controlled lentiviral vectors expressing oncogenes. Cell type- or region-specific expression of activated forms of the oncoproteins Harvey-Ras and AKT in fewer than 60 glial fibrillary acidic protein-positive cells in the hippocampus, subventricular zone or cortex of mice heterozygous for the gene encoding the tumor suppressor Tp53 were tested. Mice developed glioblastoma multiforme when transduced either in the subventricular zone or the hippocampus. However, tumors were rarely detected when the mice were transduced in the cortex. Transplantation of brain tumor cells into naive recipient mouse brain resulted in the formation of glioblastoma multiforme-like tumors, which contained CD133(+) cells, formed tumorspheres and could differentiate into neurons and astrocytes. We suggest that the use of Cre-loxP-controlled lentiviral vectors is a novel way to generate a mouse glioblastoma multiforme model in a region- and cell type-specific manner in adult mice.

Entities:  

Mesh:

Year:  2009        PMID: 19122659      PMCID: PMC2671237          DOI: 10.1038/nm.1863

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  35 in total

Review 1.  Malignant glioma: genetics and biology of a grave matter.

Authors:  E A Maher; F B Furnari; R M Bachoo; D H Rowitch; D N Louis; W K Cavenee; R A DePinho
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

2.  Neuronal or glial progeny: regional differences in radial glia fate.

Authors:  Paolo Malatesta; Michael A Hack; Eva Hartfuss; Helmut Kettenmann; Wolfgang Klinkert; Frank Kirchhoff; Magdalena Götz
Journal:  Neuron       Date:  2003-03-06       Impact factor: 17.173

3.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

4.  hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.

Authors:  L Zhuo; M Theis; I Alvarez-Maya; M Brenner; K Willecke; A Messing
Journal:  Genesis       Date:  2001-10       Impact factor: 2.487

5.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.

Authors:  E C Holland; J Celestino; C Dai; L Schaefer; R E Sawaya; G N Fuller
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

Review 6.  Gliomagenesis: genetic alterations and mouse models.

Authors:  E C Holland
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

7.  Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.

Authors:  Bo Hu; Ping Guo; Quan Fang; Huo-Quan Tao; Degui Wang; Motoo Nagane; Hui-Jein Su Huang; Yuji Gunji; Ryo Nishikawa; Kari Alitalo; Webster K Cavenee; Shi-Yuan Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

8.  Human-specific regulation of alpha 2-6-linked sialic acids.

Authors:  Pascal Gagneux; Monica Cheriyan; Nancy Hurtado-Ziola; Els C M Brinkman van der Linden; Dan Anderson; Harold McClure; Ajit Varki; Nissi M Varki
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

Review 9.  Using mice to decipher the molecular genetics of brain tumors.

Authors:  Göran Hesselager; Eric C Holland
Journal:  Neurosurgery       Date:  2003-09       Impact factor: 4.654

10.  Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy.

Authors:  Masahito Ikawa; Nobushige Tanaka; Winston W-Y Kao; Inder M Verma
Journal:  Mol Ther       Date:  2003-10       Impact factor: 11.454

View more
  166 in total

1.  Multifunctional theranostic nanoparticles for brain tumors.

Authors:  Yuhua Wang; Leaf Huang
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

2.  Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells.

Authors:  Gregory J Baker; Maria G Castro; Pedro R Lowenstein
Journal:  J Vis Exp       Date:  2015-11-28       Impact factor: 1.355

3.  Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics.

Authors:  Atsushi Fujimura; Hiroyuki Michiue; Yan Cheng; Atsuhito Uneda; Yasunari Tani; Tei-ichi Nishiki; Tomotsugu Ichikawa; Fan-Yan Wei; Kazuhito Tomizawa; Hideki Matsui
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

Review 4.  Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Authors:  Kurt M Kroeger; A K M Ghulam Muhammad; Gregory J Baker; Hikmat Assi; Mia K Wibowo; Weidong Xiong; Kader Yagiz; Marianela Candolfi; Pedro R Lowenstein; Maria G Castro
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

5.  The potential of the brain: plasticity implications for de-differentiation of mature astrocytes.

Authors:  Xing-gang Mao; Xiao-yan Xue; Xiang Zhang
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

Review 6.  Applications of lentiviral vectors for shRNA delivery and transgenesis.

Authors:  Oded Singer; Inder M Verma
Journal:  Curr Gene Ther       Date:  2008-12       Impact factor: 4.391

Review 7.  Mouse models of glioblastoma: lessons learned and questions to be answered.

Authors:  Loury Janbazian; Jason Karamchandani; Sunit Das
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

8.  Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15.

Authors:  Xing-Gang Mao; Xiang Zhang; Xiao-Yan Xue; Geng Guo; Peng Wang; Wei Zhang; Zhou Fei; Hai-Ning Zhen; Si-Wei You; Hao Yang
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

9.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

Review 10.  Gene therapy for brain tumors: basic developments and clinical implementation.

Authors:  Hikmat Assi; Marianela Candolfi; Gregory Baker; Yohei Mineharu; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.